# Cyclophosphamide

NDC: 83831-117
Generic name: Cyclophosphamide
Labeler / Manufacturer: Avyxa Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20240801

FDA application: NDA210852

## Active ingredients

- CYCLOPHOSPHAMIDE: 1 g/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83831-117"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83831-117
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f593585-e0dd-48bc-bd2b-c6c787e0b98c
